J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold? [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
Johnson & Johnson 's JNJ stock has risen 38.4% in the past six months. The stock has also been trading above its 50-day and 200-day simple moving averages (SMAs) for more than eight months since mid-June 2025 due to its positive earnings outlook and improving fundamentals. When the 50-day moving average crosses above the 200-day moving average on a stock's price chart, it's known as a "golden cross," a bullish signal suggesting potential for a prolonged upward trend. J&J's 50-day SMA has been above the 200-day SMA since it achieved the golden cross in July, suggesting that the stock is in a sustained uptrend. Zacks Investment Research Image Source: Zacks Investment Research Several factors have contributed to J&J's strong price performance, such as solid growth in sales and earnings in recent quarters, strong performance of both Innovative Medicine and MedTech segments, a bullish outlook for 2026, rapid progress in its pipeline, positive regulatory updates and regular M&A deals
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- 2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash [Yahoo! Finance]Yahoo! Finance
- Johnson And Johnson Faces Fresh Talc Verdict As Pipeline Story Evolves [Yahoo! Finance]Yahoo! Finance
- AstraZeneca News On Cancer And Asthma Raises New Questions For Investors [Yahoo! Finance]Yahoo! Finance
- Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancer [Yahoo! Finance]Yahoo! Finance
- Early study results from Johnson & Johnson show promising antitumor activity with combination of pasritamig and docetaxel in advanced prostate cancerPR Newswire
JNJ
Earnings
- 1/21/26 - Beat
JNJ
Sec Filings
- 2/27/26 - Form 144
- 2/23/26 - Form 4
- 2/20/26 - Form 144
- JNJ's page on the SEC website